TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

Currently, the study of mechanisms of development and introduction of the most effective treatment for castration-resistant prostate cancer (CRPC) – one of the most highlighted problems concerning facing oncologists and urologists worldwide. Several large randomized trials recently (TAX 327 , SWOG 9...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: T. N. Skvortsova, S. V. Mishugin, A. A. Gritskevich, I. G. Rusakov
Formato: Artigo
Idioma:Inglês
Publicado em: Bashkir State Medical University 2017-01-01
Colecção:Креативная хирургия и онкология
Assuntos:
castration-resistant cancer
prostate
docetaxel
cabazitaxel
taxanes
Acesso em linha:https://www.surgonco.ru/jour/article/view/12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados